PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...

Sami Corwin has given his Buy rating due to a combination of factors that favor PTC Therapeutics’ market position. The recent FDA approval of Kebilidi, a groundbreaking gene therapy for AADC ...

The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...

The FDA has followed in the footsteps of its European counterparts and granted accelerated approval to PTC Therapeutics’ gene ...

PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...

A piecemeal treatment approach is to be expected while research progresses, and perhaps longer-term, said Anita Jain, a long ...

More than 800 million adults have diabetes worldwide – almost twice as many as previous estimates have suggested – and more than half of those aged over 30 who have the condition are not receiving ...

Punjab Finance Minister Harpal Singh Cheema emphasises cooperative federalism and structural reforms to achieve Indias ...

Q3 marks the largest bookings in Ondas' history$14.4 million in purchase orders were from a major military customer for the Iron Drone Raider and Optimus System autonomous drone platformsIron Drone Ra ...

LONDON, GREATER LONDON, UNITED KINGDOM, November 12, 2024 /EINPresswire / -- The Business Research Company 's Early Year-End Sale! Get up to 30% off detailed market research reports-limited time only!

Read updates from clinical trials and scientific research on Huntington’s disease from Day 1 of the 2024 Huntington Study ...

CMS finalized several changes to the Medicare Shared Savings Program (MSSP), the national accountable care organization (ACO) ...